147 related articles for article (PubMed ID: 11533905)
1. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
Roick C; Ahrens B; Becker T
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
[TBL] [Abstract][Full Text] [Related]
2. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
4. Health-economic implications of the onset of action of antimanic agents.
Keck PE; McElroy SL; Bennett JA
J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
Conney J; Kaston B
Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
[TBL] [Abstract][Full Text] [Related]
6. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
7. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders.
Fritze J; Beneke M; Lanczik M; Schneider B; Walden J
Pharmacopsychiatry; 1994 Sep; 27(5):181-5. PubMed ID: 7838887
[TBL] [Abstract][Full Text] [Related]
8. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.
Keck PE; Nabulsi AA; Taylor JL; Henke CJ; Chmiel JJ; Stanton SP; Bennett JA
J Clin Psychiatry; 1996 May; 57(5):213-22. PubMed ID: 8626353
[TBL] [Abstract][Full Text] [Related]
9. Effects of divalproex versus lithium on length of hospital stay among patients with bipolar disorder.
Dalkilic A; Diaz E; Baker CB; Pearsall HR; Woods SW
Psychiatr Serv; 2000 Sep; 51(9):1184-6. PubMed ID: 10970927
[TBL] [Abstract][Full Text] [Related]
10. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller HJ; Hegerl U
Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of lithium in the prophylaxis of affective disorders].
Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
[TBL] [Abstract][Full Text] [Related]
12. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
13. Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies.
Ketter TA; Wang PW
J Clin Psychiatry; 2002; 63 Suppl 3():21-5. PubMed ID: 11908918
[TBL] [Abstract][Full Text] [Related]
14. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Keck PE; McElroy SL
J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
[TBL] [Abstract][Full Text] [Related]
16. Mortality studies and the effectiveness of drugs in long-term treatment.
Ahrens B
Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):57-61. PubMed ID: 9035229
[TBL] [Abstract][Full Text] [Related]
17. [Are mood stabilizers beneficial in the treatment of schizophrenia?].
Berle JØ; Spigset O
Tidsskr Nor Laegeforen; 2005 Jun; 125(13):1809-12. PubMed ID: 16012547
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
[TBL] [Abstract][Full Text] [Related]
19. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis.
Davis JM; Janicak PG; Hogan DM
Acta Psychiatr Scand; 1999 Dec; 100(6):406-17. PubMed ID: 10626918
[TBL] [Abstract][Full Text] [Related]
20. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
McElroy SL; Bowden CL; Collins MA; Wozniak PJ; Keck PE; Calabrese JR
J Affect Disord; 2008 Apr; 107(1-3):127-33. PubMed ID: 17888516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
